Back to
Sculptor Capital LP
CRL
13 quarters
Position history for
Sculptor Capital LP's holdings in Charles River Laboratories International, Inc.
No. Sculptor Capital Management exited its CRL (Charles River Laboratories International) position in Q1 2022. Its Q4 2021 13F listed 18,582 shares worth $7M. Sculptor Capital Management already held CRL in its Q1 2019 13F, the earliest on record, and held it in 12 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$44.3M
Total Shares Change
-305,046
Quarter-by-Quarter History
Other major holders of CRL: BlackRock Finance, Inc., Vanguard Group Inc., FMR LLC